The p53 tumor-suppressor is a transcription factor that is stabilized in response to cellular stress leading to growth arrest or apoptosis. p21 WAF1/CIP1 is a major transcriptional target of p53 and it plays a critical role in p53-dependent cell cycle arrest. In this study, we identified multiple alternate human p21 transcripts that have their transcriptional start sites in the direct proximity of the distal p53 response element. These transcripts are upregulated as a result of DNA damage-induced p53 activation. Furthermore, the basal expression of these alternate transcripts is strongly regulated by p53 and they are undetectable in p53-knocked down cells. This is in contrast to classical p21 transcripts, which have reduced, albeit detectable expression levels in the absence of p53. The existence of the alternate transcripts underscores the complexity of the human p21 genomic locus and opens up new avenues for further investigation.
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The tumor-suppressor p53 functions to maintain the integrity of the genome and is often activated in response to a variety of stress signals including DNA damage, oncogene activation and hypoxia, resulting in either cell cycle arrest or apoptosis (Giaccia and Kastan, 1998; Slee et al., 2004) . p53 is also induced by chemotherapeutic agents in wild-type p53 containing tumors and plays a crucial role in curbing the proliferation of these tumors (Lowe et al., 1994; ElDeiry, 2003) .
Although it is still controversial as to which genes mediate p53-dependent apoptosis, it has been firmly established that p21 WAF1/CIP1 is the main downstream effector of p53's growth arrest function (el-Deiry et al., 1993; Gartel et al., 1996; Gartel and Tyner, 1999) . Understandably, p21 is downregulated in a lot of cancers where its function as a negative regulator of cell-cycle might antagonize tumor growth (Gartel and Radhakrishnan, 2005) . Previously, we reported the identification of a novel p21 transcript in mice, which was dependent on p53 for its basal expression in different tissues (Gartel et al., 2004) . This transcript was highly inducible by p53 due to the unique positioning of its first exon between two p53 response elements (p53REs). In contrast to this single alternate p21 transcript in mouse, here we have showed that multiple p21 transcripts originate from a similar region in humans. In addition to being induced by p53 activation, we have showed that these transcripts also highly depend on p53 for their basal expression.
Using the BLAST search tool against the human EST database, we found the existence of three novel alternate transcripts of p21 (alt-a, alt-b and alt-c). These transcripts are shown in the genomic context in Figure 1 along with other known p21 transcripts -p21 variant-1 (classical p21 WAF1/CIP1 ) (el-Deiry et al., 1993), p21 variant-2 (Genbank accession NM_078467), p21B and p21C (Nozell and Chen, 2002) . The proximity of the transcriptional start site of the alternate transcripts to two well-known p53 binding sites suggested that these transcripts may be highly p53 responsive. In order to test this hypothesis, we treated MCF-7 human breast cancer cells (wild-type p53) with either DMSO or etoposide and assessed the levels of these alternate transcripts using RT-PCR. Etoposide treatment led to robust increase in these alternate transcripts (Figure 2a) . We also isolated these bands and sequenced them confirming that p21 alt-a and p21 alt-c have the same sequence as expected from the EST database. However, sequencing of the third band revealed that it did not match p21 alt-b , but was a variation of p21 alt-a with a longer first exon ( Figure 2b ). Hence, we named this transcript as p21 alt-a 0 . It is possible that p21 alt-b may still be expressed in some other cell lines. We also found that these alternate transcripts are induced as a result of overexpression of temperature-sensitive p53 in PC3 prostate cancer and HCT-116 colon cancer cells and in response to treatment with DNA-damaging agent doxorubicin in MCF-7 cells and after etoposide treatment in prostate cancer LNCaP and melanoma MEL-29 cells (data not shown), confirming the p53 responsiveness of these transcripts.
To see if the basal transcription of the alternate transcripts (alt-a, alt-a 0 and alt-c) depend on p53, we used the MCF-7 cell line in which p53 is knocked down Figure 2b . p21 variant-1 is the classical p21 WAF1/CIP1 transcript (el-Deiry et al., 1993) and p21 variant-2 is derived from the NCBI Refseq entry NM_078467. p21B and p21C have been described previously (Nozell and Chen, 2002) . The lengths of some of the exons are indicated. Also shown are the different primers that were used in the RT-PCR experiments. The putative protein coding regions are marked as shaded areas. The known p53 response elements (p53REs) are also indicated. þ 1 is the transcriptional start site (TSS) of the classical p21 WAF1/CIP1 (p21 variant-1).
Figure 2 p21 alternate transcripts are inducible by p53 and their basal expression depends on p53. (a) MCF-7-p53si cell line with stable knockdown of p53 was generated by transfecting a construct that expresses short hairpin RNA (shRNA) targeting p53 (a gift from Dr Gudkov, Cleveland Clinic Foundation) and the cells were selected in a medium containing 200 mg/ml of hygromycin. The MCF-7 wild type and MCF-7-p53si cells were either treated with DMSO or 10 mM etoposide for 24 h after which RNA was extracted from these cells using the RNeasy kit (Qiagen Inc., CA, USA). cDNA was synthesized using the SuperScript First Strand Synthesis Kit according to the manufacturer's recommendations (Invitrogen, Carlsbad, CA, USA). The p21 alternate transcripts were identified by PCR and the primer locations are shown in Figure 1 . Primer F1 (5 0 -GGT GGC TAT TTT GTC CTT GG-3 0 ) and primer R (5 0 -ACA GGT CCA CAT GGT CTT CC-3 0 ) amplified a 380 bp (p21 alt-a ) and 425 bp (p21 alt-a 0 ) products. Primer F2 (5 0 -GGA GGC AAA AGT CCT GTG TT-3 0 ) and primer R produced a 550 bp PCR product specific for p21 alt-c transcript. b-actin transcript levels were used as internal control and were detected using the primers 5 0 -GAG AAG ATG ACC CAG ATC ATG T-3 0 and 5 0 -TCG TCA TAC TCC TGC TTG CTG-3 0 to produce a 743 bp product. The PCR products were separated on a 1% agarose gel and visualized with ethidium bromide staining. (b) Part of the first exon of p21 alt-a and p21
alt-a 0 transcripts from the sequencing results are shown aligned with the genomic sequence. Their putative transcription start site and the p53 response element that is upstream to these exons are shown.
by stable expression of short hairpin RNA (shRNA) targeting p53 (Figure 3b ). We were not able to detect the presence of these transcripts either in the presence or absence of etoposide even in higher number of RT-PCR cycles (Figure 2a ). This suggests that p53 is required for the basal transcription of the alternate transcripts.
It is known that p53 regulates the constitutive expression of classical p21 WAF1/CIP1 at the transcriptional level in unstressed cells (Tang et al., 1998) . Having shown that the alternate transcripts (alt-a, alt-a 0 and altc) display a similar pattern, we wished to check if this was true for the less-known p21 variant-2 (Genbank accession NM_078467). To this end, we used MCF-7-p53si and HepG2-p53si cells where p53 has stably been knocked down by RNA interference (Figure 3b ). Using RT-PCR, we compared the levels of p21 variant-2 transcript in these cells with their wild-type counterparts that express p53. We saw that the levels of this transcript were significantly reduced in the absence of p53 (Figure 3a) . As expected, p21 variant-1 also showed a decrease in the p53si cells (Figure 3a) . Taken together, these data suggest that all known p21 transcripts might depend on p53 for their basal expression in the absence of stress.
In order to investigate if other prominent targets of p53 display a similar pattern, we used a series of cell lines in which p53 has been stably knocked down (MCF-7-p53si, HCT116-p53si, LNCaP-p53si and HepG2-p53si) and compared the protein levels of p21, hdm2 and PUMA with their respective wild-type counterparts that express p53. We observed a marked reduction in the levels of these target genes when p53 was depleted (Figure 3b) . The three target genes that we tested represent three distinct classes -p21 mediates cell cycle arrest (el-Deiry et al., 1993) , PUMA is responsible for cell death (Nakano and Vousden, 2001; Yu et al., 2001; Jeffers et al., 2003) and hdm2 functions as a negative regulator of p53 (Kubbutat et al., 1997) . This suggests that p53 contributes to basal transcription of its target genes, irrespective of their function.
The role of tumor-suppressor p53 is generally considered to be restricted to events after any cellular insult including DNA damage and other forms of stress. Activation and subsequent stabilization of p53 leading to induction of its target genes has been an area of intense study. Furthermore, after activation, p53 may also directly relocalize to the mitochondria and induce apoptosis independent of its trans-activation functions (Chipuk et al., 2003; Mihara et al., 2003) . Despite the availability of such a wealth of information, p53's role in unstressed cells is not very clear. A few studies indicated that p21 may depend on p53 for its basal transcription (Tang et al., 1998; Kaeser et al., 2004) . Our data here extend this observation further for other p21 transcripts and also demonstrate that targets of p53 in general may rely on p53 for their constitutive expression, thus highlighting the importance of p53 in the absence of cellular stress.
The most interesting feature of the different p21 transcripts is their degree of dependence on p53 levels. While the classical p21 transcript (variant-1) has some expression in the absence of p53 (Figure 3a) , possibly due to contribution from other transcription factors like Sp1/Sp3 (Gartel and Tyner, 1999) , the alternate transcripts are not transcribed at all in the p53 knocked down cells (Figure 2a and data not shown) . This could be due to the positioning of their transcriptional start site, which is extremely close to a p53 response element (Figures 1 and 2b) . However, both alternate and classical transcripts are upregulated in response to stress induced p53 activation (Figure 2a for alternate transcripts; unpublished observation for p21 variant-1 and -2). 0 ) produced a 434 bp product specific for p21 variant-1. Although this pair of primers was theoretically capable of amplifying p21 variant-2, only one band specific for variant-1 was observed. Primer F4 (5 0 -AGG CAC TCA GAG GAG GTG AG-3 0 ) and primer R produced a 501 bp product specific for p21 variant-2. (b) Additional cell lines with p53 knockdown (LNCaP-p53si and HCT116-p53si) were generated similar to the protocol in legend to Figure 2 . Cells were harvested in IP buffer (20 mM HEPES, 1% Triton X-100, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 100 mM NaF, 10 mM Na 4 P 2 O 7 , 1mM Na 3 VO 4 , 0.2 mM PMSF) supplemented with protease inhibitor tablet (Roche Applied Sciences). Cell lysates (75 mg) were electrophoresed on a SDS-polyacrylamide gel and transferred to polyvinylidene difluoride (PVDF) membrane (Millipore, Bedford, MA, USA). Immunoblotting was performed as indicated with antip53 antibody (sc-126 HRP; Santa Cruz, CA, USA), anti-p21 antibody (Catalog 556431; BD Pharmingen), anti-hdm2 antibody (sc-965; Santa Cruz, CA, USA), anti-PUMA antibody (a gift from Dr Yu, University of Pittsburgh Cancer Institute) and anti-b-actin antibody (A-5441; Sigma). ND -Not done.
Alternate p21 transcripts in human cells SK Radhakrishnan et al
This is in contrast to MDM2 gene where transcripts from one promoter are p53-dependent and the ones from the other are independent of p53, though both sets of transcripts code for the same protein (Bartel et al., 2002) . Apart from their dependence on p53 levels, another intriguing aspect about the alternate p21 transcripts is their existence itself. We had previously demonstrated that an alternate p21 transcript is transcribed from a similar region in mouse and that this transcript may exist in rat judging from sequence similarity (Gartel et al., 2004) . Such conservation across multiple species indicates that there could be some biological significance to these transcripts. One possibility is that the difference in 5 0 noncoding region of different transcripts of p21 could contribute to some differences in post-transcriptional stability or translational efficiency. In fact, it has been demonstrated for another cyclin dependent kinase inhibitor p18
INK4c gene, that two different transcripts with distinct 5 0 noncoding regions differ in their translational efficiency by about 50-fold (Phelps et al., 1998) . Another possibility is that transcription from the alternate promoter helps to open up the chromatin in that region to enhance the transcription from the main p21 promoter. The third possibility is that transcripts from one promoter may play a compensatory role in situations where the other promoter is silenced. There is some evidence of the main promoter being methylated in some instances of rhabdomyosarcoma tumors and lung cancer cells (Chen et al., 2000; Claus and Lubbert, 2003; Zhu et al., 2003) . One way to find out the importance of the different transcripts is to selectively knockdown the alternate or classical transcripts and see if the cell can cope with the loss under different circumstances where p21 is required. Further studies are underway to investigate each of these scenarios and to elucidate the precise biological role of these alternate transcripts.
